Evidence map›Paper›PMID 26058836›Full record

ArticlePhysiological genomics2015

Genetic variation in alpha2-adrenoreceptors and heart rate recovery after exercise.

Utkarsh Kohli, André Diedrich, Prince J Kannankeril, Mordechai Muszkat, Gbenga G Sofowora, Maureen K Hahn, Brett A English, Randy D Blakely, C Michael Stein, Daniel Kurnik

Abstract read
In one paragraph

Article in Physiological genomics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Associations BetweenBiology · 2026
    Article
  2. Article
  3. Genetics and the heart rate response to exercise.Cellular and molecular life sciences : CMLS · 2019
    Review
  4. Human Placenta Expresses αThe American journal of pathology · 2018
    Article
  5. Sexual dimorphism in heart rate recovery from peak exercise.European journal of applied physiology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Utkarsh KohliDepartment of Medicine, Vanderbilt University, Nashville, Tennessee; Department of Pharmacology, Vanderbilt University, Nashville, Tennessee; Division of Clinical Pharmacology, Vanderbilt University, Nashville, Tennessee;
André DiedrichDepartment of Medicine, Vanderbilt University, Nashville, Tennessee; Department of Biomedical Engineering Vanderbilt University, Nashville, Tennessee; Division of Clinical Pharmacology, Vanderbilt University, Nashville, Tennessee;
Prince J KannankerilDepartment of Pediatrics, Vanderbilt University, Nashville, Tennessee; Division of Clinical Pharmacology, Vanderbilt University, Nashville, Tennessee;
Mordechai MuszkatDepartment of Medicine, Vanderbilt University, Nashville, Tennessee; Division of Clinical Pharmacology, Vanderbilt University, Nashville, Tennessee;
Gbenga G SofoworaDepartment of Medicine, Vanderbilt University, Nashville, Tennessee; Department of Pharmacology, Vanderbilt University, Nashville, Tennessee; Division of Clinical Pharmacology, Vanderbilt University, Nashville, Tennessee;
Maureen K HahnDepartment of Medicine, Vanderbilt University, Nashville, Tennessee; Department of Pharmacology, Vanderbilt University, Nashville, Tennessee; Division of Genetic Medicine, Vanderbilt University, Nashville, Tennessee; and Centre for Molecular Neuroscience, Vanderbilt University, Nashville, Tennessee;
Brett A EnglishDepartment of Pharmacology, Vanderbilt University, Nashville, Tennessee; Parexel International Early Phase, Glendale, California; and.
Randy D BlakelyDepartment of Pharmacology, Vanderbilt University, Nashville, Tennessee; Department of Psychiatry, Vanderbilt University, Nashville, Tennessee; Centre for Molecular Neuroscience, Vanderbilt University, Nashville, Tennessee;
C Michael SteinDepartment of Medicine, Vanderbilt University, Nashville, Tennessee; Department of Pharmacology, Vanderbilt University, Nashville, Tennessee; Division of Clinical Pharmacology, Vanderbilt University, Nashville, Tennessee;
Daniel KurnikDepartment of Medicine, Vanderbilt University, Nashville, Tennessee; Department of Pharmacology, Vanderbilt University, Nashville, Tennessee; Division of Clinical Pharmacology, Vanderbilt University, Nashville, Tennessee; Clinical Pharmacology Unit, Section of Clinical Pharmacology and Toxicology, Rambam Health Care Campus, Haifa, Israel daniel.kurnik@vanderbilt.edu.

Funding

VANDERBILT UNIVERSITY CTSA FOR PEDIATRIC RESEARCHUL1RR024975 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$45.7M
Structural genomics of norepinephrine transportersP01HL056693 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BIAGGIONI, ITALO · 1997 to 2016
$30.8M
Clinical and Translational Training Program in Pulmonary MedicineT32HL087738 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Lorraine B Ware · 2007 to 2026
$7.0M
NCRR NIH HHS 1 UL 1 RR-024975NHLBI NIH HHS P01 HL056693NHLBI NIH HHS P01 HL-56693NHLBI NIH HHS T32 HL087738
6 · The paper itself

Abstract

Heart rate recovery (HRR) after exercise is an independent predictor of adverse cardiovascular outcomes. HRR is mediated by both parasympathetic reactivation and sympathetic withdrawal and is highly heritable. We examined whether common genetic variants in adrenergic and cholinergic receptors and transporters affect HRR. In our study 126 healthy subjects (66 Caucasians, 56 African Americans) performed an 8 min step-wise bicycle exercise test with continuous computerized ECG recordings. We fitted an exponential curve to the postexercise R-R intervals for each subject to calculate the recovery constant (kr) as primary outcome. Secondary outcome was the root mean square residuals averaged over 1 min (RMS1min), a marker of parasympathetic tone. We used multiple linear regressions to determine the effect of functional candidate genetic variants in autonomic pathways (6 ADRA2A, 1 ADRA2B, 4 ADRA2C, 2 ADRB1, 3 ADRB2, 2 NET, 2 CHT, and 1 GRK5) on the outcomes before and after adjustment for potential confounders. Recovery constant was lower (indicating slower HRR) in ADRA2B 301-303 deletion carriers (n = 54, P = 0.01), explaining 3.6% of the interindividual variability in HRR. ADRA2A Asn251Lys, ADRA2C rs13118771, and ADRB1 Ser49Gly genotypes were associated with RMS1min. Genetic variability in adrenergic receptors may be associated with HRR after exercise. However, most of the interindividual variability in HRR remained unexplained by the variants examined. Noncandidate gene-driven approaches to study genetic contributions to HRR in larger cohorts will be of interest.

Indexed as

Polymorphism, Single NucleotideAdultCatecholaminesExerciseFemaleHeart RateHumansLinear ModelsMaleReceptors, Adrenergic, alpha-2Receptors, Adrenergic, beta-1ADRA2A protein, humanADRA2B protein, humanADRA2C protein, humanADRB1 protein, humanCatecholaminesReceptors, Adrenergic, alpha-2Receptors, Adrenergic, beta-1adrenergiccholinergicheart rate recoveryparasympathetic tonepolymorphisms

Identifiers

PMID26058836
PMCPMC4556937

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.